GlassScriptPhysician profile
Amanda Figliuzzi
NPI 1982195897
$5,689.90
in general payments reported to CMS, 2019-2025
28 companies · $1,610 in 2025
The $1,610 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.87 · 2022: $593 · 2023: $1,887 · 2024: $1,520 · 2025: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,810 · Food and Beverage: $2,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,809.80 |
| Food and Beverage | $2,206.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,174.19 | 2022-2025 | |
| Medinc of Texas | $851.62 | 2023-2024 | |
| Stryker Corporation | $841.33 | 2022-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Fixos |
| Medical Device Business Services, INC. | $768.99 | 2023 | Na |
| Arthrex, INC. | $451.35 | 2024 | |
| Abbvie INC. | $308.42 | 2022-2025 | |
| Angiodynamics, INC. | $262.49 | 2023 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $137.72 | 2025 | Synchromedii |
| Paratek Pharmaceuticals, INC. | $121.41 | 2022-2024 | Nuzyra |
| Smith+Nephew, INC. | $82.89 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Anika Therapeutics, INC. | $80.87 | 2021 | |
| Bone Support INC. | $76.38 | 2025 | Cerament G, Ceramentbone Void Filler |
| Nevro Corp. | $76.23 | 2023-2024 | Senza |
| Melinta Therapeutics, LLC | $61.87 | 2023-2024 | Kimyrsa, Orbactiv |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.57 | 2022-2023 | Jublia |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $51.87 | 2024-2025 | Krystexxa |
| Bard Peripheral Vascular, INC. | $46.62 | 2025 | Fluency Endovascular Stent Graft |
| Kowa Pharmaceuticals America, INC. | $42.89 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $31.91 | 2025 | |
| Depuy Synthes Sales INC. | $29.96 | 2024 | Motoband |
| Kerecis Limited | $21.28 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $20.55 | 2025 | Exparel |
| Reprise Biomedical, INC. | $18.24 | 2025 | Miro3d |
| Solventum Corporation | $17.86 | 2025 | Activ.A.C., Promogran Prisma |
| Medline Industries LP | $16.45 | 2022 | |
| Organogenesis INC. | $14.81 | 2022 | |
| Davol INC. | $14.46 | 2023 | Arista Ah Flexitip |
| Ani Pharmaceuticals, INC. | $13.67 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Figliuzzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.